A Novel and Sensitive Spectrophotometric Approach for Quantifying Vardenafil Hydrochloride Trihydrate in Tablets: Application to Dissolution Testing
Authors:
- Amod. S. PatilAPAmod. S. Patil
- Divya MahajanDMDivya Mahajan
- Suraj R. ChaudhariSCSuraj R. Chaudhari
Open Access
- 23 September 2024
- journal article
- Published by I Publication Service
- Vol. 25 (1) , 1849-1856
Abstract
Aims: To develop and validate a novel Zero-order Absorbance UV-Spectrophotometric method for the quantification of Vardenafil Hydrochloride Trihydrate in commercial tablets and its application for dissolution testing. Background: Erectile Dysfunction (ED) is a significant disorder affecting men's sexual health, with Vardenafil being a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). Vardenafil is commonly used as an oral therapy for treating ED. Accurate and reliable methods for its quantification in pharmaceutical formulations and during dissolution tests are essential for quality control. Objective: To establish and validate a simple, accurate, precise, economical, and sensitive method for determining the concentration of Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests using UV-Spectrophotometry. Method: A Zero-order Absorbance UV-Spectrophotometric approach was employed, utilizing 0.1N HCl as the solvent. The method was optimized to determine Vardenafil hydrochloride trihydrate within a linear range of 2-12 µg/mL, with a coefficient of correlation value greater than 0.99. The method was validated for accuracy, precision, sensitivity, and ruggedness according to ICH guidelines. Additionally, the method was applied for the quantification of Vardenafil hydrochloride trihydrate in dissolution tests. Result: The method successfully determined Vardenafil hydrochloride trihydrate concentration in commercial tablets, showing a % recovery between 99.85% and 100.07%. The % amount of drug estimated was in good agreement with the label claims. The method also allowed direct measurement of samples from the dissolution vessel without pH correction. Conclusion: The developed UV-Spectrophotometric method is a reliable, accurate, and cost-effective approach for quantifying Vardenafil hydrochloride trihydrate in commercial tablets and during dissolution tests. The method's validation as per ICH guidelines ensures its suitability for routine quality control. Other: This analytical approach provides the simple and economical technique for the analysis of Vardenafil hydrochloride in pharmaceutical formulation.Keywords
This publication has 31 references indexed in Scilit:
- Physicochemical characteristics and ex vivo skin permeability for three phosphodiesterase 5 inhibitors (sildenafil, tadalafil and vardenafil): A proof-of-concept study for topical penile therapyJournal of Drug Delivery Science and Technology, 2022
- Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicinesJournal of Chromatography A, 2011
- Synthesis of core–shell magnetic molecularly imprinted polymers and detection of sildenafil and vardenafil in herbal dietary supplementsJournal of Hazardous Materials, 2011
- Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC–MS/TOFJournal of Pharmaceutical and Biomedical Analysis, 2010
- Development of an immunoassay for rapid screening of vardenafil and its potential analogues in herbal products based on a group specific monoclonal antibodyAnalytica Chimica Acta, 2010
- Development of a method for the determination of vardenafil in human plasma by high performance liquid chromatography with UV detectionBiomedical Chromatography, 2009
- Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bileJournal of Chromatography A, 2007
- Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography–electrospray ionization tandem mass spectrometryJournal of Chromatography A, 2006
- Simultaneous determination of sildenafil, vardenafil and tadalafil as forbidden components in natural dietary supplements for male sexual potency by high-performance liquid chromatography–electrospray ionization mass spectrometryJournal of Chromatography A, 2005
- Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC–ESI–MS and LC–UVJournal of Pharmaceutical and Biomedical Analysis, 2004